RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in RAPT Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −4 vs. Q3 2021
- Shares held
- 27.8M
- +1.62M (+6.2%) vs. Q3 2021
- Total value
- $1.02B
- +$207.8M (+25.6%) vs. Q3 2021
- New holders
- 17
- 28 more added
- Sold out
- 21
- 34 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Maven Securities LTD | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −32,483−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,974−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −22,080−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −19,831−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −14,262−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −11,796−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −11,156−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,623−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −9,600−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −3,283−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −670−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −598−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| Trustees of Columbia University in the City of New York | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |